159 related articles for article (PubMed ID: 4144756)
1. Drug therapy. Anticholinergics.
Greenblatt DJ; Shader RI
N Engl J Med; 1973 Jun; 288(23):1215-9. PubMed ID: 4144756
[No Abstract] [Full Text] [Related]
2. Uses and toxicity of belladonna alkaloids and synthetic anticholinergics.
Shader RI; Greenblatt DJ
Semin Psychiatry; 1971 Nov; 3(4):449-76. PubMed ID: 4154502
[No Abstract] [Full Text] [Related]
3. Antivertigo and antimotion sickness drugs.
Digregorio GJ
Am Fam Physician; 1978 Dec; 18(6):130-2. PubMed ID: 32758
[No Abstract] [Full Text] [Related]
4. [Pharmacologic agents for preventing and treating motion sickness].
Shashkov VS; Sabaev VV
Kosm Biol Aviakosm Med; 1981; 15(1):9-18. PubMed ID: 6111621
[No Abstract] [Full Text] [Related]
5. Anti-nauseant drugs.
Milton-Thompson GJ
Practitioner; 1979 Oct; 223(1336):516-9. PubMed ID: 42893
[No Abstract] [Full Text] [Related]
6. Effective doses of some cholinolytics in the treatment of anticholinesterase poisoning.
Jović R; Milosević M
Eur J Pharmacol; 1970 Sep; 12(1):85-93. PubMed ID: 4394347
[No Abstract] [Full Text] [Related]
7. Drugs for relief of nausea and vomiting.
Med Lett Drugs Ther; 1974 May; 16(11):46-8. PubMed ID: 4151675
[No Abstract] [Full Text] [Related]
8. Evaluation of anti-motion sickness drugs by body responses to labyrinthine stimulation.
Sugano H; Tominaga H
Agressologie; 1977; 18 Spec No():63-7. PubMed ID: 19980
[No Abstract] [Full Text] [Related]
9. Theory of antimotion sickness drug mechanisms.
Wood CD; Graybiel A
Aerosp Med; 1972 Mar; 43(3):249-52. PubMed ID: 4402925
[No Abstract] [Full Text] [Related]
10. Organophosphate poisoning in children - atropine, pralidoxime or both?
Nair PM; Javad H; Al-Mandhiry ZA
Saudi Med J; 2001 Sep; 22(9):814-5. PubMed ID: 11590461
[No Abstract] [Full Text] [Related]
11. Drugs for travel sickness.
Drug Ther Bull; 1981 Feb; 19(5):19-20. PubMed ID: 6112125
[No Abstract] [Full Text] [Related]
12. [Motion sickness and its treatment (author's transl)].
Petrin A
Schweiz Rundsch Med Prax; 1974 Jan; 63(3):79-81. PubMed ID: 4153225
[No Abstract] [Full Text] [Related]
13. [Optico-vestibular motion disease, altitude vertigo and clinical forms of vertigo].
Brandt T
Fortschr Med; 1976 Jul; 94(20-21):1177-82. PubMed ID: 8363
[No Abstract] [Full Text] [Related]
14. The reversal of anticholinergic intoxication in man with the cholinesterase inhibitor VX.
Sidell FR; Aghajanian GK; Groff WA; Cucinell SA
Proc Soc Exp Biol Med; 1973 Nov; 144(2):725-30. PubMed ID: 4583627
[No Abstract] [Full Text] [Related]
15. Vertigo and motion sickness. Part II: Pharmacologic treatment.
Zajonc TP; Roland PS
Ear Nose Throat J; 2006 Jan; 85(1):25-35. PubMed ID: 16509240
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic considerations on kinetoses].
Ferrotti A
Minerva Med; 1970 Apr; 61(28):1408-16. PubMed ID: 4396663
[No Abstract] [Full Text] [Related]
17. [Controlled clinical research on ketoscilium, a new parasympatholytic].
Chiarioni T; Mancini L
Clin Ter; 1969 Feb; 48(4):319-40. PubMed ID: 5355891
[No Abstract] [Full Text] [Related]
18. [Treatment of acute poisoning. 4. Treatment with specific antidotes].
Sundwall A
Lakartidningen; 1971 Mar; 68():Suppl I:79+. PubMed ID: 4997336
[No Abstract] [Full Text] [Related]
19. Choice of antihistamines.
Med Lett Drugs Ther; 1971 Dec; 13(25):102-4. PubMed ID: 4150398
[No Abstract] [Full Text] [Related]
20. Antimotion sickness drug efficacy.
Wood CD; Cramer DB; Graybiel A
Otolaryngol Head Neck Surg; 1981; 89(6):1041-4. PubMed ID: 6121316
[No Abstract] [Full Text] [Related]
[Next] [New Search]